Assignee
KNAPPERTZ VOLKER
US·1 granted patent·8 pending applications·1 citations·filing 2014–2017
Top patents by PatentIndex Score
9 records- 0166US9662322B2Laquinimod for the treatment of relapsing-remitting multiple sclerosis (RRMS) patients with a high disability statusKNAPPERTZ VOLKER·Filed 2015·Granted May 30, 2017·1 cites·28 claims
- 0257US2016184428A1Treatment of multiple sclerosis by alemtuzumab induction followed by laquinimod therapyKNAPPERTZ VOLKER·Filed 2014·Application pending·0 cites
- 0350US2015094332A1Laquinimod Combination Therapy For Treatment Of Multiple SclerosisKNAPPERTZ VOLKER·Filed 2014·Application pending·0 cites
- 0447US2016296513A1Treatment of multiple sclerosis by alemtuzumab induction followed by laquinimod therapyKNAPPERTZ VOLKER·Filed 2016·Application pending·0 cites
- 0545US2017304253A1Laquinimod Combination Therapy For Treatment Of Multiple SclerosisKNAPPERTZ VOLKER·Filed 2017·Application pending·0 cites
- 0645US2017151224A1Laquinimod for the treatment of relapsing-remitting multiple sclerosis (rrms) patients with a high disability statusKNAPPERTZ VOLKER·Filed 2017·Application pending·0 cites
- 0742US2016271094A1Laquinimod Combination Therapy For Treatment Of Multiple SclerosisKNAPPERTZ VOLKER·Filed 2016·Application pending·0 cites
- 0840US2016317525A1Treatment of multiple sclerosis with combination of laquinimod and teriflunomideKNAPPERTZ VOLKER·Filed 2014·Application pending·0 cites
- 0940US2015306088A1Laquinimod for the treatment of relapsing-remitting multiple sclerosis (rrms) patients with a high disability statusKNAPPERTZ VOLKER·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when KNAPPERTZ VOLKER files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →